Science & Technology
Testing MALT1 inhibitors as a treatment for the rare pediatric inborn error of immunity CARD11 gain of function
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43AI189037-01A1
Award Ceiling
$313K
Award Floor
$313K
Close Date
Feb 28, 2026
Total Funding
$313K
Expected Awards
1
Posted Date
Sep 22, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R43AI189037-01A1
Description
SBIR Phase Phase I award: "Testing MALT1 inhibitors as a treatment for the rare pediatric inborn error of immunity CARD11 gain of function" awarded to RAREFIED BIOSCIENCES, INC. in SANTA MONICA, California. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $313,176. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.